Urogen Pharma patent expiration

1. Jelmyto patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9950069 UROGEN PHARMA Material and method for treating internal cavities
Jan, 2031

(6 years from now)

US9040074 UROGEN PHARMA Material and method for treating internal cavities
Jan, 2031

(6 years from now)




Drug Exclusivity Drug Exclusivity Expiration
New Product(NP) Apr 15, 2023
Orphan Drug Exclusivity(ODE-289) Apr 15, 2027

Drugs and Companies using MITOMYCIN ingredient

Market Authorisation Date: 15 April, 2020

Treatment: NA

Dosage: POWDER

More Information on Dosage

JELMYTO family patents

Family Patents